Skip to main content
HUAPONT LIFE SCIENCES CO., LTD. logo

HUAPONT LIFE SCIENCES CO., LTD. — Investor Relations & Filings

Ticker · 002004 ISIN · CNE000001JJ6 LEI · 3003009TGXJC0JJVTJ07 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,461 across all filing types
Latest filing 2020-12-01 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 002004

About HUAPONT LIFE SCIENCES CO., LTD.

https://www.huapont.com.cn

HUAPONT LIFE SCIENCES CO., LTD. operates as a diversified entity specializing in the research, development, manufacturing, and distribution of pharmaceutical and chemical solutions. The company holds a prominent position in the dermatology sector, providing a comprehensive range of therapeutic products for various skin disorders. Its pharmaceutical operations extend to the production of high-quality active pharmaceutical ingredients (APIs) and finished dosage forms. Beyond human health, the organization maintains a significant footprint in the agrochemical sector, focusing on the development and supply of crop protection products, including herbicides and pesticides. The company also integrates healthcare services into its business model, overseeing the operation of medical facilities and specialized clinics. Its strategic focus centers on technological advancement and the maintenance of a robust supply chain to support its global commercial activities.

Recent filings

Filing Released Lang Actions
关于增加2020年度日常关联交易预计及预计2021年度日常关联交易公告
Regulatory Filings Classification · 95% confidence The document is a detailed announcement regarding the company's expected and actual related party transactions for the years 2020 and 2021. It includes extensive financial data on transactions with related parties, descriptions of the related parties, their financial status, and the pricing policies for these transactions. The document also contains independent directors' opinions and board meeting resolutions related to these transactions. It is not a full annual or interim financial report, nor is it a simple announcement of a report. It is a regulatory announcement focused on related party transactions, which is a common type of regulatory filing in Chinese markets. Given the detailed nature and the focus on compliance and disclosure of related party transactions, this fits best under the category of Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2020-12-01 Chinese
独立董事关于第七届董事会第二十次会议相关事项的事前认可意见和独立意见
Board/Management Information Classification · 95% confidence The document is a formal statement from independent directors of a company regarding their opinions on specific corporate matters, including credit limits, guarantees, related party transactions, and foreign exchange hedging activities. It references compliance with governance rules and legal regulations, and it is dated December 1, 2020. The content is focused on independent directors' opinions and approvals related to board meeting agenda items and shareholder meeting submissions. It does not contain financial statements, earnings data, or detailed financial analysis. It is not a full annual or interim report, nor is it a call transcript or earnings release. The document is a governance-related statement expressing independent directors' opinions on corporate governance matters and approvals, which fits best under Board/Management Information (MANG). The document length is short (1695 characters), and it is not an announcement of a report publication but a substantive governance opinion document.
2020-12-01 Chinese
关于公司及控股子公司2021年度向银行申请授信额度及担保事项的公告
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement from Huabang Life Health Co., Ltd. regarding the company's and its subsidiaries' application for credit limits and guarantee matters with banks for the year 2021. It includes extensive information about the credit and guarantee amounts, the subsidiaries involved, their financial data, and the board and independent directors' opinions approving the credit and guarantee proposals. The document is not a financial report like an annual or interim report, nor is it a transcript, audit report, or remuneration information. It is a formal announcement about financing activities, specifically about credit applications and guarantees, which fits the category of Capital/Financing Update (CAP). The document length is substantial and contains substantive details about financing arrangements, not just a brief notice or regulatory filing. Therefore, the appropriate classification is CAP with high confidence.
2020-12-01 Chinese
2020年度第二期超短期融资券（疫情防控债）兑付完成公告
Capital/Financing Update Classification · 95% confidence The document is a short announcement regarding the completion of payment (redemption) of a short-term financing bond issued by the company. It includes details such as bond code, issuance date, amount, interest rate, maturity date, and confirmation of payment completion. There is no detailed financial report or analysis, only a notice about the financing bond repayment. This fits the definition of a Capital/Financing Update (CAP) as it relates to company financing activities and capital structure changes. The document length is short and it is not an announcement of a report publication, so it is not RPA. Therefore, the correct classification is CAP with high confidence.
2020-11-30 Chinese
关于参加“2020年重庆辖区上市公司投资者网上集体接待日活动”的情况公告
Regulatory Filings Classification · 90% confidence The document is a detailed announcement about the company's participation in an investor online reception day event, including Q&A with investors on various business topics such as product lines, market strategy, financial status, and future plans. It is not a financial report, earnings release, or regulatory filing. It is a communication aimed at investor relations and interaction rather than a formal report or announcement of voting results, capital changes, or management changes. The document length is 4213 characters, which is relatively short but contains substantive Q&A content rather than just a notice or link to a report. Therefore, it fits best as a Regulatory Filing (RNS) since it is a general regulatory announcement that does not fit other specific categories.
2020-11-27 Chinese
关于参加“2020年重庆辖区上市公司投资者网上集体接待日活动”的通知公告
Investor Presentation Classification · 90% confidence The document is a notice about the company's participation in an investor online collective reception day event, including details about the event time, platform, and company representatives attending. It does not contain financial statements, earnings data, or detailed report content. It is an announcement related to investor relations activities rather than a formal report or transcript. The document length is short (794 characters), and it is clearly an announcement of an event rather than a report or transcript. Therefore, it fits best under Investor Presentation (IP) as it focuses on investor communication and company strategy discussion in a presentation-like format.
2020-11-20 Chinese

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.